CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Director	Common Stock	Common Stock Director	Additional Paid-in Capital	Additional Paid-in Capital Director	Accumulated Deficit	Treasury Stock
Beginning balance, shares outstanding at Dec. 31, 2024			15,254
Beginning balance at Dec. 31, 2024	$ 208,550		$ 269		$ 243,825		$ 243,209	$ (278,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	20,926						20,926
Issuance of common stock from employee stock purchase plan (in shares)			11
Issuance of common stock from employee stock purchase plan	367				367
Issuance of common stock to former executive (in shares)			271	2
Issuance of common stock to former executive	0	$ 77	$ 3		(3)	$ 77
Issuance of restricted common stock (in shares)			115
Issuance of restricted common stock	0		$ 1		(1)
Exercise of stock options (in shares)			77
Exercise of stock options	321				321
Restricted common stock, performance awards, and stock options surrendered for taxes paid (in shares)			(49)
Restricted common stock, performance awards, and stock options surrendered for taxes paid	(7,629)				(7,629)
Stock-based compensation expense	1,676				1,676
Dividends on common stock	(1,722)				(1,722)
Other (in shares)			(12)
Other	496				496
Ending balance, shares outstanding at Mar. 31, 2025			15,693
Ending balance at Mar. 31, 2025	223,062		$ 273		237,407		264,135	(278,753)
Beginning balance, shares outstanding at Dec. 31, 2025			15,751
Beginning balance at Dec. 31, 2025	254,776		$ 274		238,539		294,716	(278,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	13,492						13,492
Issuance of common stock from employee stock purchase plan (in shares)			10
Issuance of common stock from employee stock purchase plan	360				360
Issuance of common stock to former executive (in shares)				1
Issuance of common stock to former executive		$ 63				$ 63
Issuance of restricted common stock (in shares)			110
Issuance of restricted common stock	0		$ 1		(1)
Exercise of stock options (in shares)			45
Exercise of stock options	0		$ 0		0
Restricted common stock, performance awards, and stock options surrendered for taxes paid (in shares)			(46)
Restricted common stock, performance awards, and stock options surrendered for taxes paid	(2,072)				(2,072)
Stock-based compensation expense	2,033				2,033
Dividends on common stock	(1,772)				(1,772)
Other (in shares)			(1)
Other	59				59
Ending balance, shares outstanding at Mar. 31, 2026			15,872
Ending balance at Mar. 31, 2026	$ 266,939		$ 275		$ 237,209		$ 308,208	$ (278,753)